Posted on December 22, 2014 by Sitemaster
A study just published in European Urology has suggested that early therapy with Prostvac-type vaccines might have value in the management of men with a rising PSA after first-line therapy. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: progressive, Prostvac, PSA, rising, vaccine | 2 Comments »
Posted on November 15, 2014 by Sitemaster
A newly published paper by some highly regarded researchers provides data from a small, Phase II trial of Prostate Health Cocktail (PHC) — an “over-the-counter” combination herbal supplement — in the management of biochemical recurrence of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical, PSA, reccurrence, rising, supplement, Treatment | 3 Comments »
Posted on January 16, 2014 by Sitemaster
According to a media release we saw this morning, a company called Madison Vaccines has started a Phase II clinical trial of a new form of immunotherapy for treatment of men with non-metastatic prostate cancer and rising PSA levels prior to any treatment with androgen deprivation therapy (ADT). … READ MORE …
Filed under: Drugs in development, Management, Treatment, Uncategorized | Tagged: MVI-816, non-metastatic, progressive, PSA, pTVG-HP, rising, trial | 2 Comments »
Posted on October 21, 2008 by Sitemaster
In this month’s online issue of Oncology, you can read a full review by Moul et al. (not just the abstract) addressing the complexities of the management of a rising PSA in men with histologically proven but non-metastatic prostate cancer, i.e., men who have failed definitive therapy for localized disease or men who are initially diagnosed with progressive disease. … READ MORE …
Filed under: Management, Treatment | Tagged: non-metastatic, PSA, rising | Leave a comment »
